Cargando...
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a pote...
Gardado en:
| Publicado en: | Clin Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889265/ https://ncbi.nlm.nih.gov/pubmed/29636932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1430 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|